Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bispecific antibodies.
Fanger MW, Morganelli PM, Guyre PM. Fanger MW, et al. Among authors: guyre pm. Crit Rev Immunol. 1992;12(3-4):101-24. Crit Rev Immunol. 1992. PMID: 1476620 Review.
Production and use of anti-FcR bispecific antibodies.
Fanger MW, Graziano RF, Guyre PM. Fanger MW, et al. Among authors: guyre pm. Immunomethods. 1994 Feb;4(1):72-81. doi: 10.1006/immu.1994.1009. Immunomethods. 1994. PMID: 8069530 Review.
Fc gamma RI blockade and modulation for immunotherapy.
Wallace PK, Keler T, Guyre PM, Fanger MW. Wallace PK, et al. Among authors: guyre pm. Cancer Immunol Immunother. 1997 Nov-Dec;45(3-4):137-41. doi: 10.1007/s002620050416. Cancer Immunol Immunother. 1997. PMID: 9435857 Free PMC article.
Pharmacokinetic-pharmacodynamic relationships of the bispecific antibody MDX-H210 when administered in combination with interferon gamma: a multiple-dose phase-I study in patients with advanced cancer which overexpresses HER-2/neu.
Lewis LD, Cole BF, Wallace PK, Fisher JL, Waugh M, Guyre PM, Fanger MW, Curnow RT, Kaufman PA, Ernstoff MS. Lewis LD, et al. Among authors: guyre pm. J Immunol Methods. 2001 Feb 1;248(1-2):149-65. doi: 10.1016/s0022-1759(00)00355-0. J Immunol Methods. 2001. PMID: 11223076 Clinical Trial.
123 results